BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1809065)

  • 21. A scheme for the evaluation of methods in clinical chemistry with particular application to those measuring enzyme activities. Part II: analysis of data and performance assessment.
    Kim EK; Logan JE
    Clin Biochem; 1978 Dec; 11(6):244-50. PubMed ID: 737849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood alcohol testing: comparison of the performance obtained with the different methods used in the Belgian external quality assessment schemes.
    Devleeschouwer N; Libeer JC; Martens FK; Neels H; Van Damme M; Verstraete A; Deveaux M; Wallemacq PE
    Clin Chem Lab Med; 2004 Jan; 42(1):57-61. PubMed ID: 15061381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External quality assurance model for improvement of specificity and accuracy of serum hormone determinations in the Nordic countries.
    Ruokonen A; Hyltoft-Petersen P; Blaabjerg O
    Ups J Med Sci; 1990; 95(3):257-8. PubMed ID: 2100403
    [No Abstract]   [Full Text] [Related]  

  • 24. Standardized LC-MS/MS based steroid hormone profile-analysis.
    Koal T; Schmiederer D; Pham-Tuan H; Röhring C; Rauh M
    J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):129-38. PubMed ID: 22210511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External quality control performance in clinical chemistry: experience in Kenya.
    Mbiti MJ; Ojwang PJ; Orinda DA
    East Afr Med J; 1993 Apr; 70(4 Suppl):16-20. PubMed ID: 8223301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoassay external quality assessment in Italy: HBsAg and anti-HBs tests.
    Pizzocolo G; Malvano R; Pilloton E; Signorini C; Zanetti A; Albertini A
    Ann Ist Super Sanita; 1991; 27(3):487-93. PubMed ID: 1809069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CNR external quality assessment program for immunoassays: statistical analysis and reports for participants.
    Pilo A; Zucchelli GC; Chiesa MR; Masini S; Clerico A
    Ann Ist Super Sanita; 1991; 27(3):469-77. PubMed ID: 1809067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of performance of assays for serum growth hormone in the United Kingdom (UK): evidence from the UK external quality assessment scheme, 1980-1987.
    Seth J; Hanning I; Bacon RR; Hunter WM
    Clin Chim Acta; 1988 May; 174(2):171-83. PubMed ID: 3383442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Between-country comparability of clinical chemistry results: an international quality assessment survey of 17 analytes in six European countries through existing national schemes.
    Jansen RT; Bullock DG; Vassault A; Baadenhuijsen H; De Leenheer A; Dumont G; de Verdier CH; Zender R
    Ann Clin Biochem; 1993 May; 30 ( Pt 3)():304-14. PubMed ID: 8517614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why do immunoassays for tumour markers give differing results?--a view from the UK National External Quality Assessment Schemes.
    Sturgeon CM; Seth J
    Eur J Clin Chem Clin Biochem; 1996 Sep; 34(9):755-9. PubMed ID: 8891529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sample distribution programme for erythropoietin.
    Marsden JT; Day P; Ellis R; Marwah S; Savage G; Sinclair C
    Clin Lab Haematol; 2006 Aug; 28(4):228-32. PubMed ID: 16898959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy-based assessment of proficiency testing results with serum from single donations: possibilities and limitations.
    Stöckl D; Libeer JC; Reinauer H; Thienpont LM; De Leenheer AP
    Clin Chem; 1996 Mar; 42(3):469-70. PubMed ID: 8598118
    [No Abstract]   [Full Text] [Related]  

  • 33. Components of quality control.
    Hurley AA
    Curr Protoc Cytom; 2001 May; Chapter 3():Unit 3.2. PubMed ID: 18770705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Can laboratories rely on diagnostics-companies?].
    Ekman R; Fernlund P; Forberg R; Isaksson A; Lindstedt G; Hellsing K; Hård L; Nyström E
    Lakartidningen; 2000 May; 97(22):2783. PubMed ID: 10900904
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of favourable treatment of samples on indices of performance in external quality assessment schemes.
    Rumley AG; Roberts LB
    Ann Clin Biochem; 1982 May; 19(3):171-5. PubMed ID: 7092143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoassay external quality assessment in the Federal Republic of Germany.
    Wood WG
    Ann Ist Super Sanita; 1991; 27(3):495-8. PubMed ID: 1809070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diluent Multiassay for the MODULAR ANALYTICS E170 does not improve TSH dilutions compared to Diluent Universal.
    Rigo RF; Alía P; Rosel P; Navarro MA
    Clin Chem Lab Med; 2006; 44(3):353-4. PubMed ID: 16519611
    [No Abstract]   [Full Text] [Related]  

  • 38. Commutability of reference materials in clinical chemistry.
    Franzini C
    J Int Fed Clin Chem; 1993 Sep; 5(4):169-73. PubMed ID: 10146393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new quality control model using performance goals based on biological variation in External Quality Assurance Schemes.
    Mina A
    Clin Chem Lab Med; 2006; 44(1):86-91. PubMed ID: 16375592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Our experience with quality control in current growth hormone assays.
    Bidlingmaier F; Geilenkeuser WJ; Kruse R; Röhle G
    Horm Res; 1991; 36 Suppl 1():1-4. PubMed ID: 1806476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.